The present invention relates to compounds of formula (I): wherein
--X--Y--, R.sup.1 to R.sup.11 and n are as defined in the description and
claims, and pharmaceutically acceptable salts thereof. The compounds are
useful for the treatment and/or prevention of diseases which are mediated
by CETP inhibitors.